Selection of modified oligonucleotides with increased target affinity via MALDI-monitored nuclease survival assays

Journal of Combinatorial Chemistry

Volumn 1, Issue 6, 1999, Pages 493-508

  Altman, Robert K ^a   Schwope, Ina ^a,b   Sarracino, David A ^a   Tetzlaff, Charles N ^a   Bleczinski, Colleen F ^a   Richert, Clemens ^a  

^a TUFTS UNIVERSITY   (United States)

^b EPIGENOMICS AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; OLIGONUCLEOTIDE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; RNA;

ARTICLE; AUTOMATION; CHEMISTRY; COMBINATORIAL CHEMISTRY; DNA DENATURATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; SYNTHESIS;

AUTOMATION; COMBINATORIAL CHEMISTRY TECHNIQUES; DNA; NUCLEIC ACID DENATURATION; OLIGONUCLEOTIDES; PHOSPHODIESTERASE I; PHOSPHORIC DIESTER HYDROLASES; RNA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0033223759     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc9900293     Document Type: Article

References (8)

1. Selected reviews: (a) Uhlmann, E.; Peyman, A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 1990, 90, 544-584. (b) Milligan, J. F.; Matteucci, M. D.; Martin, J. C. Current concepts in antisense drug design. J. Med. Chem. 1993, 36, 1923-1937. (c) DeMesmaeker, A.; Haener, R.; Martin, P.; Moser, H. E. Antisense Oligonucleotides. Ace. Chem. Res. 1995, 28, 366-374. (d) Crooke, S. T. Antisense therapeutics. Biotechnol. Genet. Eng. Rev. 1998, 15, 121-157.
2. Selected reviews: (a) Uhlmann, E.; Peyman, A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 1990, 90, 544-584. (b) Milligan, J. F.; Matteucci, M. D.; Martin, J. C. Current concepts in antisense drug design. J. Med. Chem. 1993, 36, 1923-1937. (c) DeMesmaeker, A.; Haener, R.; Martin, P.; Moser, H. E. Antisense Oligonucleotides. Ace. Chem. Res. 1995, 28, 366-374. (d) Crooke, S. T. Antisense therapeutics. Biotechnol. Genet. Eng. Rev. 1998, 15, 121-157.
3. Selected reviews: (a) Uhlmann, E.; Peyman, A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 1990, 90, 544-584. (b) Milligan, J. F.; Matteucci, M. D.; Martin, J. C. Current concepts in antisense drug design. J. Med. Chem. 1993, 36, 1923-1937. (c) DeMesmaeker, A.; Haener, R.; Martin, P.; Moser, H. E. Antisense Oligonucleotides. Ace. Chem. Res. 1995, 28, 366-374. (d) Crooke, S. T. Antisense therapeutics. Biotechnol. Genet. Eng. Rev. 1998, 15, 121-157.
4. Selected reviews: (a) Uhlmann, E.; Peyman, A. Antisense oligonucleotides: a new therapeutic principle. Chem. Rev. 1990, 90, 544-584. (b) Milligan, J. F.; Matteucci, M. D.; Martin, J. C. Current concepts in antisense drug design. J. Med. Chem. 1993, 36, 1923-1937. (c) DeMesmaeker, A.; Haener, R.; Martin, P.; Moser, H. E. Antisense Oligonucleotides. Ace. Chem. Res. 1995, 28, 366-374. (d) Crooke, S. T. Antisense therapeutics. Biotechnol. Genet. Eng. Rev. 1998, 15, 121-157.
5. (e) Helene, C.; Giovannangeli, C.; Guieysse-Peugeot, A. L.; Praseuth, D. Sequence-specific control of gene expression by antigene and clamp oligonucleotides. CIBA Symp. Ser. 1997, 209, 94-102.
6. Berkenkamp, S.; Kirpekar, F.; Hillenkamp, F. Infrared MALDI mass spectrometry of large nucleic acids. Science 1998, 281, 260-262.
7. Sannes-Lowery, K. A.; Mack, D. P.; Hu, P. F.; Mei, H. Y.; Loo, J. A. Positive ion electrospray ionization mass spectrometry of oligonucleotides. J. Am. Soc. Mass Spectrom. 1997, 8, 90-95.
8. Service, R. F. Microchip arrays put DNA on the spot. Science 1998, 282, 396-399.